Investments

Clinical Candidates

Over ten GHIT development partnerships have conducted clinical programs worldwide.
Please see each program to know more details.

  • SILVAMPTM TBLAM

    1. Disease: Tuberculosis
    2. Intervention: Diagnostics
    3. Development Stage: Field Validation
    4. Country: South Africa, Malawi, Zambia, Tanzania, Uganda, Vietnam, Thailand
    Details
  • Photo credit: Biopromic AB

    BP-AK urine LAM test

    1. Disease: Tuberculosis
    2. Intervention: Diagnostics
    3. Development Stage: Product Development
    4. Country: South Africa, Uganda
    Details
  • Lung Flute ECO

    1. Disease: Tuberculosis
    2. Intervention: Diagnostics
    3. Development Stage: Field Validation
    4. Country: Cameroon
    Details
  • SJ733

    1. Disease: Malaria
    2. Intervention: Drug
    3. Development Stage: Phase IIa
    4. Country: Peru
    Details
  • BK-SE36/CpG & NPC-SE36/CpG

    1. Disease: Malaria
    2. Intervention: Vaccine
    3. Development Stage: Phase IIb
    4. Country: Burkina Faso
    Details
  • SMAART-1

    1. Disease: Malaria
    2. Intervention: Diagnostics
    3. Development Stage: Product Development
    4. Country: Democratic Republic of Congo
    Details
  • Arpraziquantel

    1. Disease: Schistosomiasis
    2. Intervention: Pediatric Drug
    3. Development Stage: Phase III, Registration, Access
    4. Country: Côte d’Ivoire, Kenya
    Details
  • Fosravuconazole

    1. Disease: Mycetoma
    2. Intervention: Drug
    3. Development Stage: Phase II
    4. Country: Sudan
    Details
  • Photo credit: Vinicius Berger-DNDi

    CpG-D35

    1. Disease: Cutaneous leishmaniasis
    2. Intervention: Drug
    3. Development Stage: Phase I
    4. Country: UK, Columbia
    Details
  • Photo credit: Kate Dodd

    AWZ1066S

    1. Disease: Lymphatic filariasis / Onchocerciasis
    2. Intervention: Drug
    3. Development Stage: Phase I
    4. Country: UK
    Details
  • Photo credit: FIND

    BU-MYCOLAC

    1. Disease: Buruli ulcer
    2. Intervention: Diagnostics
    3. Development Stage: Product Development
    4. Country: Cameroon, Côte d'Ivoire
    Details
  • Photo credit: CONICET-INGEBI

    Trypanosoma cruzi-LAMP

    1. Disease: Chagas disease
    2. Intervention: Diagnostics
    3. Development Stage: Product Development
    4. Country: Argentina, Bolivia, Paraguay
    Details
  • SCH CAA RDT

    1. Disease: Schistosomiasis
    2. Intervention: Diagnostics
    3. Development Stage: Product Development
    4. Country: Kenya, Philippines
    Details